Clinical Trial Update: Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing hyperthermia with mitomycin C to Bacillus Calmette-Guérin (BCG) immunotherapy for superficial bladder cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Bacillus Calmette-Guérin (Bacillus Calmette-Guérin)
• Mitomycin-C (mitomycin C)

Snippet

Sponsor: Medical Enterprises Europe B.V. | Conditions: Urinary Bladder Diseases, Urinary Bladder Neoplasms | Phase 3 | Status: TERMINATED